Möchten Sie immer auf dem neuesten Stand bleiben?

Certara's Simcyp Simulator enabled modeling predictions accepted by the FDA in lieu of clinical studies to support the approval of asciminib.

Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "AI in Biotechnology Market by Function (Drug Design & Optimization, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply...

MENLO PARK, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- SPARK NS today announced the nine projects and principal investigators selected for the SPARK NS Translational Research Program, 2026 Cohort....

Austin, United States, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Drug Discovery Informatics Market Size & Growth Analysis: According to SNS Insider, The Drug Discovery Informatics Market size is...

BCC Research report, “Botanical and Plant-derived Drugs: Global Markets” is expected to grow from $38.7 billion in 2025 to $58.1 billion by the end of 2030

SPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease Progression

DURHAM, NC and LONDON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, today announced the expansion of its Xenon MRI...

Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform

Avance Clinical will meet biotech sponsors at Biotech Showcase 2026 in San Francisco, highlighting the launch of the new Early Phase Center of Excellence.

First patient dosed and study open in leading oncology centers in US and AustraliaPhase I/IIA adaptive study aims to assess and optimize the dose of OTP-01 and provide safety, tolerability, and early...